Hypertension and the Cortisol-Cortisone Shuttle
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
11 beta-Hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) plays a crucial role in converting hormonally active cortisol to inactive cortisone, thereby conferring specificity on the mineralocorticoid receptor. Mutations in the gene encoding 11 beta-HSD2 (HSD11B2) account for an inherited form of hypertension, the syndrome of apparent mineralocorticoid excess, in which cortisol induces hypertension and hypokalemia. A similar clinical picture to apparent mineralocorticoid excess occurs after the ingestion of licorice and carbenoxolone, which are competitive inhibitors of 11 beta-HSD2. Reduced 11 beta-HSD2 activity may explain the increased sodium retention in preeclampsia, renal disease, and liver cirrhosis. Substrate saturation of 11 beta-HSD2 occurs in Cushing's syndrome and explains the mineralocorticoid excess state that characterizes ectopic ACTH syndrome. Polymorphic variability in the HSD11B2 gene in part determines salt sensitivity, a forerunner for adult onset hypertension. Furthermore, reduced placental 11 beta-HSD2 expression might underpin the Barker hypothesis, the epidemiological link between reduced birth weight and adult hypertension. At a prereceptor level, 11 beta-HSD2 plays a key role in normal physiology in the corticosteroid regulation of sodium homeostasis and pathophysiology of hypertension.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Heterozygous carriers may have an increased risk of hypertension (598).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [598]
Citations
Cites
Barker, D. J., Osmond, C., Golding, J., Kuh, D., & Wadsworth, M. E. (1989) · BMJ · doi:10.1136/bmj.298.6673.564 · Cited by 2,415 · cited 1×
“Barker’s epidemiological studies indicate a strong correlation between low birth weight at term and cardiovascular disease risk in adulthood, and this has prompted speculation that factors involved in regulating fetal growth might in some way program the subsequent development of hypertension (and other cardiovascular…”
BackgroundArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946 · cited 1×
“and aldosterone in vitro (4), and the inactivation of cortisol to”
BackgroundMineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationStewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803 · cited 1×
“Licorice administration to normal volunteers results in a mineralocorticoid excess state, an increase in the urinary THF allo-THF/THE ratio, an increase in plasma cortisol half-life, and a decrease in circulating cortisone values, indicative of inhibition of 11 HSD2 in vivo (30, 31).”
BackgroundSelf-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationCloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712
Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase
Mune, T., Rogerson, F. M., Nikkilä, H., Agarwal, A. K., & White, P. C. (1995) · Nature Genetics · doi:10.1038/ng0895-394 · Cited by 619
Edwards, C. R. W., Benediktsson, R., Lindsay, R. S., & Seckl, J. R. (1993) · The Lancet · doi:10.1016/0140-6736(93)90148-a · Cited by 548 · cited 1×
“The poor growth rate seen in many children with AME is possibly due to glucocorticoid excess in utero consequent on absent or impaired 11 -HSD2 activity (66, 67).”
Background11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Cited by
Items 201–284 of 284
Pseudohypoaldosteronism Type 1
Cheong, H. I. (2013) · Journal of genetic medicine · doi:10.5734/jgm.2013.10.2.81 · Cited by 3
Genetic Influences on Hormonal Markers of Chronic HPA Function in Human HairPreprint
Tucker–Drob, E. M., Grotzinger, A. D., Briley, D. A., Engelhardt, L. E., Mann, F. D., Patterson, M. W., Kirschbaum, C., Adam, E. K., Church, J. A., Tackett, J. L., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/055244 · Cited by 3
Colussi, G. (2003) · New England Journal of Medicine · doi:10.1056/nejm200310023491420 · Cited by 3
Lase, I., Grönberg, M., Welin, S., & Janson, E. T. (2025) · ESMO rare cancers. · doi:10.1016/j.esmorc.2025.100013 · Cited by 2
Wu, W., Wang, Z., Yang, W., Feng, X., Yang, Y., Xu, M., Li, B., Wu, P., & Cao, Z. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.127450 · Cited by 2
Gürsoy, S., Bodur, S., Atakol, A., & Bakırdere, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-38457-z · Cited by 2
Stewart, P. M. (2013) · Medicine · doi:10.1016/j.mpmed.2013.06.010 · Cited by 3
Self-citationNeuroendocrine Control of the Vascular System
Dalmasso, C., & Loria, A. S. (2023) · Masterclass in neuroendocrinology · doi:10.1007/978-3-031-39995-4_3 · Cited by 4
Chen, Z., Wei, D., Zhao, M., Shi, J., Ma, C., Zhang, C., Lin, H., Huo, W., Wang, C., Fan, C., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003758 · Cited by 3
“…conversion capacity in hypertensive patients [18] This altered profile may enhance the biological potency of F, thereby heightening the risk of hypertension [19,20] The balance and relative proportion of F and its metabolite E in the human body may affect the occurrence of hypertension 21].”
Tetrandrine inhibits aldosterone synthesis by covalently targeting CYP11A1 to attenuate hypertension
Chu, S., Yang, W., Lu, Y., Li, J., Peng, J., Liu, W., Jiang, M., & Bai, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1387756 · Cited by 3
Stress responses in blood donors: Oral fluid hormone dynamics and implications for donor support
Alterio, A., Feltracco, M., Mazzi, G., Rosso, B., Prosdocimi, L., & Gambaro, A. (2025) · Steroids · doi:10.1016/j.steroids.2025.109604 · Cited by 2
11β-Hydroxysteroid Dehydrogenases in the Regulation of Tissue Glucocorticoid Availability
Pereira, C., Monteiro, R., Constância, M., & João, M. (2012) · InTech eBooks · doi:10.5772/53645 · Cited by 3
“…present with sodium retention, hypertension and hypokalemia (Anagnostis et al., 2009; Andrews et al., 2003; Edwards et al., 1988; Gathercole & Stewart, 2010; Monder et al., 1986; Mune et al., 1995; Palermo et al., 2004; Quinkler & Stewart, 2003; Stewart et al., 1996; Walker, B. & An‐ drew, 2006).”
Background11β-Hydroxysteroid Dehydrogenase Type 1 and the Metabolic Syndrome
Cidalia, D., Maria, J., Azevedo, I., & Monteiro, R. (2011) · InTech eBooks · doi:10.5772/28641 · Cited by 2
“…normal circulating levels of cortisol and an intact HPA axis (Anagnostis et al., 2009; Andrews et al., 2003; Edwards et al., 1988; Gathercole & Stewart, 2010; Monder et al., 1986; Mune et al., 1995; Palermo et al., 2004; Quinkler & Stewart, 2003; Stewart et al., 1996; Walker & Andrew, 2006).”
BackgroundThe Role of Aldosterone Blockade in Patients with Hypertensive Heart and Cardiovascular Disease
Pitt, B. (2010) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s2232 · Cited by 3
[Laboratorial diagnosis of Cushing's syndrome].
Alves, M., Neves, C., & Medina, J. L. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.20344/amp.594 · Cited by 14
Gold star–carbon nanotube composite for analysing preeclampsia during pregnancy
Huo, G., Qin, Y., Bao, X., Yao, X., Pu, Z., Sun, J., & Gopinath, S. C. B. (2020) · Applied Physics A · doi:10.1007/s00339-020-3287-0 · Cited by 5
Hypertension and Adrenal Gland Disease
Jepson, R. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-33020-0_4 · Cited by 3
Kolatkar, N. S., Thomas, A., & Williams, G. H. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420018905.002 · Cited by 2
Stewart, P. M. (2009) · Medicine · doi:10.1016/j.mpmed.2009.05.012 · Cited by 2
Self-citationMineralocorticoid Effects in Cushing’s Disease: A Case Report
Pereira, V. R., Silva, B. C., Castanheira, D., Ferreira, G., & de Almeida, R. S. (2024) · Cureus · doi:10.7759/cureus.75780 · Cited by 2
Plasma cell-free extrachromosomal circular DNA is a molecular hallmark of preeclampsia
Han, P., Zhang, C., Ge, F., Liu, C., Fu, J., Lv, W., Jin, X., Zhang, J., Zhao, L., Luo, Y., et al. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.06.020 · Cited by 1
“All four genes have been reported to be associated with PE [44 – 47]; however, their presence in eccDNA is revealed for the first time by our study.”
Tang, Q., Yao, H., Zhou, Y., Xin, C., Yuan, X., Cao, J., Chen, X., Lu, Y., Deng, A., Du, J., et al. (2025) · Journal of Chromatography A · doi:10.1016/j.chroma.2025.466429 · Cited by 1
Dhaybi, O. A., & Bhatt, D. L. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71029 · Cited by 1
Toralles, M. B. P., Kalil, J. R., Cerqueira, L. A., & Alves, C. D. A. D. (2007) · Revista Brasileira em Promoção da saúde · doi:10.5020/1010 · Cited by 3
Barnes, V. A., & Orme‐Johnson, D. W. (2008) · RICYDE Revista Internacional de Ciencias del Deporte · doi:10.5232/ricyde2008.01201 · Cited by 5
Ritz, E. (2006) · Cited by 1
Severe Hypertensive Episode Associated With Excess Licorice Consumption
Rachman‐Elbaum, S., & Johnson, T. W. (2014) · Topics in Clinical Nutrition · doi:10.1097/01.tin.0000445900.05642.od · Cited by 1
Apparent Mineralocorticoid Excess
Yau, M., & Nimkarn, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00017-x · Cited by 1
Primary Mineralocorticoid Excess Syndromes and Hypertension
Carey, R. M., & Padia, S. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00107-6 · Cited by 1
Cao, Y., Yang, S., Yili, J., Tuersun, N., Wang, Z., Cai, X., Rong, L., & Wu, T. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_18 · Cited by 3
Clinical diagnosis and treatment of apparent mineralocorticoid excess
Yau, M., Nimkarn, S., Macdonald, A., & New, M. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00029-0 · Cited by 1
Liquorice-Induced Hypokalaemia and Rhabdomyolysis
Kronborg-White, S. B., & Roseva-Nielsen, C. N. (2013) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v3i4-5.181 · Cited by 1
“GZA and its metabolites inhibit the enzyme 11β-hydroxysteroid dehydrogenase and subsequent increases activity of cortisol on the mineralocorticoid receptors [1, 2].”
Background68-jährige Patientin mit Dyspnoe und hypokaliämischer Hypertonie
Müssig, K., Maser‐Gluth, C., Hartmann, M. F., Wehrmann, M., Horger, M., Kanz, L., Häring, H.-U., & Wudy, S. (2007) · Der Internist · doi:10.1007/s00108-007-1930-x · Cited by 2
[Ectopic ACTH syndrome and severe hypokalaemia].
Servonnet, A., Delacour, H., Roux, X., Dehan, C., Gardet, V., & Morand, C. (2007) · PubMed · Cited by 1
Ehret, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42973-3.00006-8 · Cited by 4
Hydrosaline Alterations in Cushing Disease
Alcubierre, D. D., Sbardella, E., & Isidori, A. M. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_15 · Cited by 1
Subclinical Cushing Syndrome Presenting With Hypertension and Hypokalemia
Torun, A. N. İ., Gürsoy, A., Ünal, A. D., & Demirağ, N. G. (2007) · The Endocrinologist · doi:10.1097/ten.0b013e31813435ea · Cited by 1
Harada, E., Yasue, H., Mizuno, Y., Morikawa, Y., Nakagawa, H., Semba, F., Yoshimura, M., & Saito, Y. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.4089 · Cited by 3
“Aging is also associated with chronic inflammation and kidney disease which may impair 11β-HSD2 activity (14, 17).”
BackgroundInfluentialKasuya, Y., Yokokawa, A., Hamura, K., Shibasaki, H., & Furuta, T. (2005) · Steroids · doi:10.1016/j.steroids.2005.05.004 · Cited by 1
内分泌性高血圧症:診断と治療の進歩 III.原発性アルドステロン症の類縁疾患 3.偽性アルドステロン症
洋孝, 柴. (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.671 · Cited by 1
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 2
Understanding the Relationship between Skin Color, Vitamin D, and Blood Pressure.
Griffin, F. C. (2010) · Deep Blue (University of Michigan)
Weber, C. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10872 · Cited by 1
Hansen, M. H., Kristensen, S. S., de Muckadell, O. B. S., Thiesson, H. C., Andrew, R., & Fialla, A. D. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.690044 · Cited by 1
“Established treatment of this disorder includes dexamethasone [21], which support the importance of our findings in this study.”
ResultA complicated case of atrial fibrillation
Delsignore, E., Cantone, R., Moia, M. L., Olivetto, L., Pollo, M. C., Varese, A. M., Tua, A., & Bertoncelli, M. C. (2015) · Clinical Management Issues · doi:10.7175/cmi.v4i3s.1149
68-jährige Patientin mit Dyspnoe und hypokaliämischer Hypertonie
Werdan, K., & Verlag, S. M. (2007)
Kosicka, K., Główka, F. K., Cymerys, M., & Chuchracki, M. (2010)
Katedra i Zakład Farmacji Fizycznej i Farmakokinetyki
Kosicka, K. (2011)
Hasegawa, N., Ohara, M., & Mochizuki, M. (2015) · Health · doi:10.4236/health.2015.710149
“Blood cortisol is known to be converted into cortisone by 11βHDS2, and cortisone is to be converted into cortisol by 11βHDS1 (cortisol-cortisone shuttle) [7].”
BackgroundGene-environment Interactions Underlying the Developmental Origins of Health and Disease
Knight, B. S. (2008) · TSpace (University of Toronto)
Interactions plantes et médicaments post-greffe : participation à HEDRINE
Chaudier, R. (2013) · HAL · Cited by 1
Treatment for Symptoms of Pseudoaldosteronism
Shibata, H., & Ito, H. (2007) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.96.805
Licorice Consumption causing Hypokalemia and Lethal Dysrhythmias
Grosscup, G. (2014) · Digital Commons - Otterbein (Otterbein University)
Mulatero, P., Monticone, S., & Goi, J. (2025) · Vitamins and hormones · doi:10.1016/bs.vh.2025.08.007
Fox, E., & Lalwani, K. (2015) · Springer eBooks · doi:10.1007/978-1-4614-7495-1_195
三衛, 石. (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.482
Endocrine Hypertensive Emergencies
Egan, C. E., Greenberg, J. A., & Fahey, T. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_42
Conceição-Vertamatti, A. G. (2016) · doi:10.47749/t/unicamp.2016.967882
Fuller, P. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00099-x
Pitt, B. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3927-2.10033-8
Brown, N. J. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717948900.793454000
Hajleh, M. N. A., & Al‐Dujaili, E. A. S. (2022) · International Electronic Conference on Nutrients (IECN) · doi:10.3390/iecn2022-12398
Pereira, A. M., & Dekkers, O. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00006-8
Case 1-2023: A 49-Year-Old Man with Hypokalemia and Paranoia
Vokoun, C. W., Murphy, M. C., Reynolds, K. L., & Haines, M. S. (2023) · New England Journal of Medicine · doi:10.1056/nejmcpc2211366
Stifel, U., Vogel, F., Caratti, G., Reincke, M., & Tuckermann, J. P. (2023) · medRxiv · doi:10.1101/2023.02.28.23286599
“primarily in liver and adipose tissue and appears to have a role in arterial hypertension [63, 69, 75].”
BackgroundHydrosaline Alterations in Cushing Disease
Alcubierre, D. D., Sbardella, E., & Isidori, A. M. (2023) · Endocrinology · doi:10.1007/978-3-030-44628-4_15-1
Malwe, A. S., Mondal, S., Harlapur, P., & Sharma, V. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.09.539941 · Cited by 1
Sirenko, Y., & Rekovets, О. L. (2023) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.3.2023.1268
Ehret, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00006-2
Blutdruckexazerbation durch zu viel Lakritz
Dreher, L. (2024) · CardioVasc · doi:10.1007/s15027-024-3531-1
Albritton, C. F., Demirci, M., Neikirk, K., Ertuğlu, L. A., Ishimwe, J., Mutchler, A. P., Sheng, Q., Laffer, C. L., Wanjalla, C. N., Ahmed, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.10.598374 · Cited by 3
“16–18 Excess cortisol and 11-deoxycortisol, as well as elevated cortisol-to-cortisone ratios, have been implicated in hypertension 19 .”
BackgroundLong-term complications of hypercortisolism
Pivonello, R., Crescenzo, E. M., Simeoli, C., Paola, N. D., Larocca, A., & Colao, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00123-0
Lee, J., Tomkins, M., McDonald, D., Martin‐Grace, J., Carthy, C., Finnegan, J., Mulholland, D., Dugal, N., Hill, A. D. K., O’Reilly, M., et al. (2025) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-24-0137
Beyond Expectations: The Astonishing Physiology of Motherhood
Karaca, S. Y. (2026) · Springer eBooks · doi:10.1007/978-3-032-15221-3_1
Ding, X., Hou, X., & Deng, H. (2026) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519426400233
Kaur, M. (2026) · Physiology in clinical neurosciences · doi:10.1007/978-981-92-0763-3_5
Li, Y., 梁晓慧, Cao, L., Yang, Y., Wei, S., & Ji, Y. H. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1790465
“The 11 beta-HSD2 can play a crucial role in converting hormonally active cortisol to inactive cortisone (15, 118, 119).”
Ghafari, N., Brukner, D., Nawaito, S. A., Berbrier, D. E., Usselman, C. W., Pilon, N., & Sleno, L. (2026) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.6c00096
Fichna, M., Rogowicz‐Frontczak, A., Komarowska, H., Fichna, P., Sowińska, A., & Ruchała, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9661229/v1
Endocrine Hypertension in Children and Adults: Beyond Primary Aldosteronism
Salle, S. P., Puthukara, A., Vaidya, A., & Bhatt, G. C. (2026) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2026.04.002
Regulation of the Mineralocorticoid Receptor in Physiology and Disease
Young, M. J., Fuller, P. J., Meijer, O. C., Cole, T. J., Kanki, M., Yang, J., Ho, Q. V., Karthigan, N., & Heanue, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100156
Hypercortisolism: An Under‐Recognised Pathway Linked to Multi‐System Complications
Sacoto, H. D., & Fonseca, V. A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71149
“When 11β-HSD2 is oversaturated by excess cortisol, the MR is inappropriately activated, leading to increased sodium and water retention [49, 60–63].”
Monogenic Kidney Disorders as Hidden Drivers of Electrolyte Imbalance and Hypertension
Ahn, Y. H. (2026) · Electrolytes & Blood Pressure · doi:10.5049/ebp.2026.24.e15
Farmaci interferenti sul metabolismo pre-recettoriale dei glicocorticoidi
Borretta, G., & Pia, A. R. (2008) · L Endocrinologo · doi:10.1007/bf03344614
Metadata
- Authors
- Quinkler, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Corresponding author
- Stewart, Paul M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2384-2392
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087582614
- Semantic Scholar
- 776fe230acf2defba35d92035bb5d6c7ce782d64
- Cited by
- 286
- References
- 70
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 15 · 2019: 6 · 2018: 11 · 2017: 11 · 2016: 10 · 2015: 13 · 2014: 12 · 2013: 13 · 2012: 14
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hypertension, 11β-hydroxysteroid dehydrogenase type 2, mineralocorticoid receptor, apparent mineralocorticoid excess, licorice, carbenoxolone, preeclampsia, sodium retention, Cushing's syndrome, ectopic ACTH syndrome, salt sensitivity, Barker hypothesis, fetal growth restriction, sodium homeostasis, substrate saturation
- MeSH terms
- Cortisone, Humans, Hydrocortisone, Hydroxysteroid Dehydrogenases, Hypertension, Mineralocorticoids, 11-beta-Hydroxysteroid Dehydrogenase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.